← Eichor
Study identifier: NCT03900286 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Low Energy Diet and Familial Partial Lipodystrophy

Condition: Lipodystrophy · Diabetes · Diet Modification  ·  Sponsor: Cambridge University Hospitals NHS Foundation Trust

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

To evaluate the therapeutic efficacy and metabolic impact of a low energy diet (LED) in people with familial partial lipodystrophy and diabetes. Participants will be provided with a LED (total diet replacement) for 12 weeks, before the introduction of a stepped food transition. Metabolic effects will continue to be assessed for 1 year. In order to better understand why this intervention changes insulin sensitivity, we will also collect adipose and muscle tissue samples at baseline and 12 weeks into the intervention in participants willing to have these procedures performed. These samples will be used for histological, metabolite, gene expression and protein expression analyses.

This description comes directly from the study's public registry record.

Talk to the study team

Mandour O Mandour  ·  01223768625  ·  mom30@cam.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Cambridge University Hospital NHS Foundation TrustCambridge, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03900286